May 13th 2024
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Ultrasonography models effective at determining lesion type
July 21st 2023In a recent study, high sensitivity and specificity were found for differentiating between benign and malignant lesions when using the Assessment of Different Neoplasias in the Adnexa and Ovarian-Adnexal Reporting and Data System models.
Read More
The value of HPV self-sampling kits
May 31st 2023Jeff Andrews, MD, FRCSC, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, discusses the link between human papillomavirus (HPV) and cervical cancer, and how HPV self-sampling kits may increase rates of cervical cancer screening.
Read More
FDA approves dostarlimab for dMMR endometrial cancer
February 10th 2023The FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.
Read More
Current US HPV and Cervical Cancer Screening Guidelines
May 26th 2022Emily K. Hill, MD, reviews the current US HPV and cervical cancer screening guidelines from the American Cancer Society, American College of Obstetricians and Gynecologists, and the American Society for Colposcopy and Cervical Pathology and discusses the differences within.
Watch
Awareness and Outreach for Cervical Cancer Screening
May 13th 2022Drs Mark H. Stoler, Emily K. Hill, Sangini S. Sheth, and Thomas C. Wright comment on the general awareness around HPV and cervical cancer in patients as well as the importance of increasing routine cervical cancer screening approaching those conversations with patients.
Watch